CAMP4 Therapeutics
CAMP----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: CAMP4 Therapeutics(CAMP) predict that the Revenue is 1.294 M (+50.82%), Beat estimate;the EBIT is -13.07 M (+0.22%), Miss estimate;the EPS is -0.32 (+48.39%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B50.82%
0.00B30.30%
+0.00B20.52%
EBITMiss expectations
-0.01B0.22%
-0.01B4.75%
-0.00B4.53%
EPSMiss expectations
-0.3248.39%
-0.2166.13%
-0.110017.74%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf